Toggle Side Panel
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
More options
Sign in
Sign up
Search for:
News + Resources
Market Trends
Downloads & Resources
CDMO News
CRO News
Biotech Profiles
Podcast
Directory
Events
CDMO Live Europe
CDMO Live Americas
ExM Leaders
Search for:
Close search
Policy Briefings
Section 232 Pharma Tariffs Expand Today: What Manufacturers Need to Know
MFN Deal Includes Revenue-Sharing With HHS on Overseas Sales
China Aims for 25% of Global First-in-Class Drugs by 2030
White House Secures $19.6B in Pharma Manufacturing Pledges
Trump Gives Generic Drugmakers Two Years to Reshore Before Tariffs Hit
Warren, Scott revive bill to map foreign control of US drug supply
Congress Proposes Federal Oversight for US-China Drug Licensing Deals
FDA Shakeup Continues: Høeg Fired, Davis Named Acting CDER Head
Trump Confirms Makary Exit; Diamantas Named Acting Chief
Regeneron Closes MFN Deal; Offers Gene Therapy Free
US Pharma Tariffs: 100% Headline Rate, Far Lower Real-World Impact
The European Biotech Act, Explained
Multistate Lawsuit Targets CDC Childhood Vaccine Rollback
Trump’s Tariffs Are Off — Or Are They? What Pharma Does Next
FDA and EMA Issue Joint AI Principles for Drug Development
EU Critical Medicines Act: What Manufacturing Leaders Must Prepare For
TrumpRx Launches: Will Direct-to-Consumer Platform Actually Lower Drug Costs?
J&J Strikes Drug Pricing Deal with Trump Administration
Nine Drugmakers Sign Trump MFN Deals in Single Day, Pledge $150B in US Manufacturing
US–UK Deal Sets Zero Tariffs, Raises UK Drug Value Thresholds
Trump Administration Launches Review of Global Drug Pricing Practises
« Previous
Page
1
Page
2
Next »
Nanoform Partners With European CDMO to Advance Biologics Technology
Made Scientific Partners With Orca Bio on Commercial Manufacturing of TREGZI
OXB Confirms Manufacturing Partnership With Aura Biosciences for Phase 3 Cancer Therapy
Gene2Cure Partners With Viralgen to Advance Three Rare Disease Gene Therapy Programs
Lonza Signs Global Exclusive License Deal With CMS for Brain Delivery Technology
AGC Biologics Secures Three Cell Therapy Projects for New Yokohama Site
AGC Biologics Partners With Pyramid Pharma Services to Expand US Fill-Finish Capabilities
LOTTE Biologics Secures First Major Commercial Deal for Songdo Plant 1
CorePharma Expands CDMO Capabilities With New Spray Drying Technology
Andelyn Biosciences to Manufacture Celliaz’s Investigational RP Gene Therapy
Toxys and Charles River Partner to Expand Access to Two NAMs Assays
NorthX Biologics and Mendus Expand Cell Therapy Manufacturing Collaboration
Evonik Manufactures First GMP Lipid Batch at New US Facility
Curia Completes $5.48 Million Investment in León, Spain Facility
BDR Pharma Expands CDMO Capabilities With Acme Formulation Acquisition
ProBio Licenses Discovery-Stage Oncology Antibody Asset to AbTis
AGC Biologics Partners With Child’s Cure on mRNA Therapy for CDKL5 Disorder
ProBioGen Expands GMP Manufacturing to Viral Vectors and Vaccines
« Previous
Page
1
Page
2
Page
3
Page
4
Page
5
Next »
European CDMO Landscape 2025:
Download the latest edition